Achieve life sciences to present at life science innovation northwest 2023 conference

Seattle and vancouver, british columbia, april 14, 2023 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that john bencich, ceo of achieve, will present at the life science innovation northwest (lsinw) 2023 conference being held at the seattle convention center april 25-26, 2023.
ACHV Ratings Summary
ACHV Quant Ranking